Greater inotropic and cyclic AMP responses evoked by noradrenaline through Arg389 β1‐adrenoceptors versus Gly389 β1‐adrenoceptors in isolated human atrial myocardium
Authors:
Open Access
- 30 January 2003
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 138 (2) , 386-392
Abstract
We studied the biochemical and contractile responses of isolated human myocardial tissue expressing native receptor variants of the 389G>R β1‐adrenoceptor polymorphism. Right atrial appendage was obtained from homozygous RR patients (n=37) and homozygous GG patients (n=17) undergoing elective cardiac surgery. The positive inotropic effect of noradrenaline in these tissues, mediated through β1‐adrenoceptors, was studied using electrically stimulated (1 Hz) atrial strips, as well as the effects of noradrenaline on cyclic AMP levels and cyclic AMP‐dependent protein kinase. Tissue from RR homozygotes (n=14) showed significantly increased inotropic potency to noradrenaline (−log EC50, M=6.92±0.12) compared to GG homozygotes (n=8, −log EC50, M=6.36±0.11, P−1) were also greater in RR homozygotes (basal 34.8±3.7 n=12, 300 nM noradrenaline 41.4±7.6 n=9, 30 μM noradrenaline 45.2±3.2 n=22, 0.2 mM isoprenaline 48.3±4.2 n=16) compared to GG homozygotes (basal 30.7±4.4 n=5, 300 nM noradrenaline 32.6±6.92 n=5, 30 μM noradrenaline 38.1±3.1 n=8, 0.2 mM isoprenaline 42.6±5.2 n=6, P=0.007). There were no differences between the variants in terms of cyclic AMP‐dependent protein kinase activity. These data provide the first evidence that enhanced G‐protein coupling of the R389 β1‐adrenoceptor variant reported in rodent fibroblast expression systems is also present in native human receptors. The functional consequence of this is to significantly alter the inotropic potency of β1‐adrenoceptor activation depending on its genotype at the 389 position. British Journal of Pharmacology (2003) 138, 386–392. doi:10.1038/sj.bjp.0705030Keywords
This publication has 27 references indexed in Scilit:
- A Polymorphism in the β1 Adrenergic Receptor Is Associated with Resting Heart RateThe American Journal of Human Genetics, 2002
- Amino Acid 49 Polymorphisms of the Human β 1 -Adrenergic Receptor Affect Agonist-Promoted TraffickingJournal of Cardiovascular Pharmacology, 2002
- Influence of β1-adrenoceptor blockade on the gene expression of adenylate cyclase subtypes and β-adrenoceptor kinase in human atriumClinical Science, 2001
- Polymorphism in the β 1 -Adrenergic Receptor Gene and HypertensionCirculation, 2001
- Arg389Gly ??1-adrenoceptor polymorphism varies in frequency among different ethnic groups but does not alter response in vivoPharmacogenetics, 2001
- Influence of age on left atrial appendage function in patients with nonvalvular atrial fibrillationClinical Cardiology, 2001
- A novel polymorphism in the gene coding for the beta1-adrenergic receptor associated with survival in patients with heart failureEuropean Heart Journal, 2000
- The gain-of-function G389R variant of the β1-adrenoceptor does not influence blood pressure or heart rate response to β-blockade in hypertensive subjectsClinical Science, 2000
- A Gain-of-function Polymorphism in a G-protein Coupling Domain of the Human β1-Adrenergic ReceptorJournal of Biological Chemistry, 1999
- Effects of (−)‐RO363 at human atrial β‐adrenoceptor subtypes, the human cloned β3‐adrenoceptor and rodent intestinal β3‐adrenoceptorsBritish Journal of Pharmacology, 1997